November 10, 2014
1 min read

IL-6 serum an ineffective diagnostic tool for postoperative shoulder infection

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Measured levels of serum interleukin-6 were not effective as a diagnostic tool for infection following shoulder arthroplasty, according to recently published data.

Researchers prospectively studied 69 patients who underwent revision shoulder arthroplasty at a single institution between 2010 and 2013. In addition to standard measures to check for infection both pre- and intraoperatively, preoperative serum interleukin-6 (IL-6) measurements were taken in all patients.

Patients were categorized into groups based on their likelihood of infection (group 1: certain; group 2: probable; group 3: possible; group 4: none).

No infection was observed in 32 patients. Among the 24 patients classified as groups 1 or 2, IL-6 levels were not found to be a significant marker of infection based on sensitivity or specificity, according to the researchers.

The majority of patients in groups 1 or 2 (83%) were found to have the organism Propionibacterium acnes; however, the researchers found IL-6 was not a sensitive marker of infection in these patients. In fact, sensitivity of IL-6 was found to be lower than that of erythrocyte sedimentation rate and C-reactive protein levels.

In cases not involving P. acnes — one involving Staphylococcus aureus, one involving Enterobacter cloacae and two involving coagulase-negative Staphylococcus species — IL-6 sensitivity was 25%, according to the researchers.

Disclosure: The authors have no relevant financial disclosures.